Pfeil Keith W 4

What Happened
Keith W. Pfeil, President, CEO and a director of Globus Medical, was granted 100,000 derivative equity awards on January 21, 2026. The Form 4 reports an acquisition price of $0.00 (derivative), so the filing shows $0 in immediate cash value; a footnote specifies these are options that vest over a four‑year schedule.

Key Details

• Transaction date: January 21, 2026; Form 4 filed January 23, 2026 (timely filing).
• Award: 100,000 derivative shares reported at $0.00 acquisition price (transaction code A = Award/Grant).
• Vesting: 1/4 of the options vest on January 1, 2027, then 1/48 of the total vests each month thereafter (per footnote).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• No sale or exercise occurred — this is a grant/long‑term compensation, not a market transaction.

Context
This is a typical equity compensation grant to an executive rather than a purchase or sale; the options vest over time to align incentives. Because it’s a derivative award, there’s no immediate stock transfer or cash proceeds reported here — value to the executive will depend on future vesting and any applicable exercise price and market performance.